Global Knee Bursitis Market Size Projected to Reach $3.72 Billion During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Knee Bursitis Market Over The Five-Year Period 2025–2029?

The knee bursitis market size has experienced significant expansion in recent years. It is anticipated to increase from $2.66 billion in 2024 to $2.86 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.3%. The growth observed in prior periods can be attributed to factors such as an aging population, greater involvement in sports and physical activities, advancements in diagnostic techniques, enhanced accessibility to healthcare services, and educational programs for medical professionals and patients.

The knee bursitis market size is anticipated to undergo significant expansion over the next few years. It is predicted to reach $3.72 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.8%. This projected increase can be linked to factors such as enhanced awareness initiatives concerning prevention and management, a rise in disposable income, growing healthcare spending, and improved recognition and diagnosis of knee bursitis. Prominent trends expected in the forecast period encompass advancements in diagnostic methods, the introduction of novel therapies, progress in research and development endeavors, and the implementation of telemedicine and remote monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Knee Bursitis Industry?

The escalating prevalence of bone-related diseases is anticipated to spur expansion in the knee bursitis market moving forward. These conditions encompass ailments such as osteoporosis, arthritis, and bone cancer, which negatively affect the skeletal system’s structure, strength, and overall function. The increasing incidence of bone-related illnesses is attributed to various factors including an aging global population, sedentary lifestyles, inadequate nutrition, and shifts in environmental conditions. Specifically, bone-related issues like osteoarthritis and rheumatoid arthritis can lead to knee bursitis by inducing inflammation and excessive pressure on the knee bursa. This inflammation, in turn, manifests as pain, swelling, and reduced functionality of the joint. For example, in September 2022, a report published by Healthy Bones Australia, an Australia-based non-profit organization, projected that in 2022, an estimated 6.2 million individuals in Australia, aged 50 and above, were affected by either osteoporosis or osteopenia. This figure is based on the calculation that among the 4.74 million Australians with poor bone health, 22% suffer from osteoporosis and 78% from osteopenia. Therefore, the growing prevalence of bone-related diseases is a key driver for the growth of the knee bursitis market.

How Is The Knee Bursitis Market Segmented?

The knee bursitismarket covered in this report is segmented –

1) By Diagnosis: Imaging Test; Other Diagnosis Tests

2) By Treatment: Medication; Therapy; Surgery; Other Treatments

3) By End User: Hospitals And Clinics; Diagnostic Centers; Research Centers; Academic Institutes; Other End Users

Subsegments:

1) By Imaging Test: X-Ray; MRI (Magnetic Resonance Imaging); Ultrasound

2) By Other Diagnosis Tests: Physical Examination; Aspiration Of Joint Fluid; Blood Tests

Which Key Players Are Driving Competition In The Knee Bursitis Market?

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

How Is Knee Bursitis Market Demand Varying Across Different Regions?

North America was the largest region in the knee bursitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Knee Bursitis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Browse Through More Reports Similar to the Global Knee Bursitis Market 2025, By The Business Research Company

Knee Implants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report

Total Hip And Knee Replacements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/total-hip-and-knee-replacements-global-market-report

Healthcare Reimbursement Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-reimbursement-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795